Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	645	709	1,093	3,960	8,087	3,720
Market Cap Growth	-4.22%	-35.07%	-72.41%	-51.03%	117.39%	-
Enterprise Value	609	569	798	3,441	7,282	3,035
Last Close Price	4.42	4.90	7.64	28.06	59.13	29.92
PS Ratio	3.65	4.17	5.90	25.66	82.20	43.73
PB Ratio	2.91	2.30	2.35	6.56	10.88	6.51
P/TBV Ratio	7.48	3.85	3.23	8.31	13.17	8.45
P/FCF Ratio	-	-	-	-	-	19.16
P/OCF Ratio	-	-	-	-	-	18.11
EV/Sales Ratio	3.44	3.34	4.31	22.29	74.02	35.68
EV/FCF Ratio	-	-	-	-	-	15.63
Debt / Equity Ratio	1.00	0.74	0.50	0.18	0.15	0.06
Debt / FCF Ratio	-	-	-	-	-	0.19
Asset Turnover	0.28	0.22	0.21	0.15	0.10	0.14
Inventory Turnover	11.59	13.68	11.84	11.50	11.98	11.00
Quick Ratio	3.26	4.38	4.91	3.27	6.66	7.56
Current Ratio	3.52	4.66	5.12	3.54	6.91	7.82
Return on Equity (ROE)	-66.76%	-58.34%	-37.52%	-30.77%	-22.25%	-15.70%
Return on Assets (ROA)	-16.37%	-16.60%	-14.06%	-12.81%	-9.42%	-7.87%
Return on Capital (ROIC)	-20.07%	-20.40%	-17.71%	-16.67%	-13.09%	-10.76%
Earnings Yield	-29.83%	-31.75%	-18.32%	-5.23%	-1.81%	-1.84%
FCF Yield	-17.50%	-23.54%	-18.33%	-6.43%	-2.08%	5.22%
Buyback Yield / Dilution	-1.73%	-1.31%	-1.54%	-6.96%	-89.71%	-447.64%
Total Shareholder Return	-1.73%	-1.31%	-1.54%	-6.96%	-89.71%	-447.64%

Source: S&P Capital IQ. Standard template. Financial Sources.